Heart Failure: The Expert's Approach

Section 1:: The Emergency Department

• How to Evaluate Dyspnea in the Emergency Department
• Heart Failure Disposition:: When to Admit, When to Observe, and When to Discharge Home
• The Treatment of Acute Heart Failure in the Emergency Department
• Management of Atrial Fibrillation in Patients with Heart Failure and Preserved and
• Low Ejection Fractions
• How to Use Natriuretic Peptides in the Emergency Department
• How to Use New Biomarkers in the Emergency Department
• The Role of Ultrasound in the Management of Acute Heart Failure
• Use of Bioelectrical Impedance Vector Analysis in the Dyspneic Patient
• Mechanical Ventilation in Acute Heart Failure:: The Role of Noninvasive Ventilation
• Emergency Department Observation Unit:: Management of Congestive Heart Failure
• When to Employ Cardiac Magnetic Resonance Imaging and Cardiac Computed Tomography in the Evaluation of Heart Failure
• When to Discharge the Heart Failure Patient

Section 2:: Heart Failure in the Hospital

• How to Use Natriuretic Peptides in the Inpatient Setting?
• Approaches to Diuretics in the Hospital
• Vasodilators in Acute Heart Failure
• When and How to Use Inotropes?
• New Cardiovascular Disease Biomarkers in Hospital Medicine:: Neutrophil Gelatinase-associated Lipocalin
• Practical Approach to Hyponatremia in Heart Failure
• Heart Failure and Acute Coronary Syndrome
• The ABCs of Isolated Venovenous Ultrafiltration in Fluid-overloaded Heart Failure Patients
• Who Should Receive a Pulmonary Artery Catheter

Section 3:: Chronic Heart Failure in the Outpatient Setting

• Outpatient Follow-up—What Should We Monitor
• Echocardiography:: Getting It Right
• A Practical Guide for Reducing Readmissions in Heart Failure
• Initiation of Angiotensin-converting Enzyme Inhibitors and Beta Blockers in Heart Failure:: Putting Evidence into Practice
• Mineralocorticoid Receptor Antagonists in Patients with Heart Failure and a Reduced Left Ventricular Ejection Fraction:: How to Do It Right
• Atrial Fibrillation Done Right
• Ventricular Tachycardia Done Right
• Issues in Anticoagulation
• Management of the Patient with Heart Failure with Preserved Ejection Fraction
• Implantable Cardioverter-defibrillator and Cardiac Resynchronization Therapy in
• Heart Failure Patients:: How to Choose the Right Device for the Right Patients
• Clinical Decision-making in the Outpatient Setting:: The Use of Galectin-3
• Guiding Heart Failure Care with Natriuretic Peptides
• ST2:: How to Really Do It Right
• Using Cardiac Troponin to Assist in the Management of Patients with Congestive Heart Failure—A Practical Guide
• Biomarkers on the Horizon for Chronic Heart Failure

Section 4:: Special Issues in Heart Failure

• Sex Differences in Heart Failure:: Implications for Clinical Practice
• Chronic Heart Failure in Geriatric Patients
• How to Diagnose and Treat Anemia in Patients with Heart Failure
• Diabetes Management in Heart Failure
• Heart Failure in Europe
• Heart Failure in Southeast Asia
• Heart Failure in India
• Heart Failure in India:: Clinical Perspective
• Heart Failure in China
• Heart Failure from the US Veterans Health Administration Perspective:: A Patient-centered Approach to Care
• Heart Failure in the Nursing Home Setting
• Heart Failure from the Nursing Perspective
• Developing Heart Failure Service in a Developing Nation:: Borneo Malaysia Perspective

Section 5:: Advanced Heart Failure

• Approach to the End-stage Heart Failure Patient
• Left Ventricular Assist Device Versus Transplantation:: How to Decide
• Approach to Left Ventricular Assist Devices and Follow-up in Advanced Congestive Heart Failure
• How to Approach Palliative and End-of-life Care
• Percutaneous Mechanical Circulatory Support in Cardiogenic Shock

Section 6:: Cardiomyopathies:: Practical Recommendations to Diagnosis and Management

• New Onset Cardiomyopathy:: Biopsy or MRI and Other Imaging Modalities
• Hypertrophic Cardiomyopathy
• Takotsubo Cardiomyopathy
• Myocarditis
• When is Genetic Testing Necessary?
• AIDS-induced Cardiac Abnormalities and Heart Failure
• Prohormone Levels in Heart Failure